11 July 2016

Director/PDMR Shareholding


Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it was notified today that David Evans, Chairman of the Company, has today purchased 900,000 ordinary shares in the Company ("Ordinary Shares") at 6.0 pence per Ordinary Share.

Following this transaction, David Evans’ total beneficial holding in the Company has increased to 14,788,730 Ordinary Shares representing 8.6 per cent. of the issued ordinary share capital of the Company.



Collagen Solutions Plc  
Jamal Rushdy, CEO Mob: +1 612 405 7709
Gill Black, CFO Tel: 0141 648 9100
Panmure Gordon & Co (Nominated Adviser and Broker)  
Freddy Crossley, Duncan Monteith (Corporate Finance) Tel: 020 7886 2500
Maisie Atkinson (Corporate Sales) Tel: 020 7886 2905
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.